TP53 and myelodysplastic syndrome: Suppression of TP53 with dexamethasone or Cenersen, a TP53 antisense oligonucleotide targeting TP53 mRNA, results in a reduction of apoptosis and restoration of erythropoiesis in del(5q) MDS progenitors [85].